Universal Corporation — Form 10-Q summary
Reporting-period clarification: The supplied filing is for the quarter ended September 30, 2021, and covers the first six months of fiscal 2022 (year ending March 31, 2022). This does not match the request metadata of “2020 Q2.”
Business context and period
Universal is a global business-to-business supplier of leaf tobacco and plant-based food ingredients. Its Tobacco Operations source, process, and sell tobacco; Ingredients Operations produce fruit and vegetable ingredients. Results are seasonal, and quarterly results may not indicate full-year performance. Comparisons below are with the corresponding 2020 periods.
Financial performance
| Metric | Three months ended September 30 | Six months ended September 30 |
|---|---|---|
| Revenue | $454.0 million, up 20% from $377.0 million | $804.0 million, up 16% from $692.8 million |
| Gross margin | Filing highlights do not provide a clear quarterly comparison | 19.3%, versus 17.7% |
| Operating income | $29.8 million, versus $16.4 million | $40.4 million, versus $24.9 million |
| Net income attributable to Universal | $19.5 million, versus $7.5 million | $25.9 million, versus $14.8 million |
| Diluted EPS | $0.78, versus $0.30 | $1.04, versus $0.60 |
For the six-month period, operating cash flow was negative $120.8 million, compared with negative $150.0 million in 2020. Capital expenditures were $18.6 million, versus $22.8 million. Operating cash use reflected seasonal working-capital needs, including tobacco inventory purchases; tobacco inventory was $854.3 million at September 30, up $213.7 million from March 31.
At September 30, cash and cash equivalents were $100.7 million; current assets were $1.66 billion and current liabilities were $399.4 million. Short-term notes payable and overdrafts were $185.0 million, and long-term debt was $518.4 million. The company reported net debt to net capitalization of approximately 33%, versus 31% a year earlier and 25% at March 31, 2021. It had $350 million available under its committed revolving facility and about $169 million in unused uncommitted credit lines. No long-term debt matures until fiscal 2024. The company was in compliance with debt covenants.
Dividends declared were $0.78 per share for the quarter and $1.56 for the six-month period. No shares were repurchased during the quarter; $100 million remained authorized under the repurchase program.
Material changes and operating drivers
- Tobacco Operations revenue rose 5% for the six months to $690.6 million, and segment operating income increased 52% to $35.8 million. Management attributed the improvement mainly to a more favorable mix, including more lamina and fewer lower-margin carryover sales, higher prices, and additional value-added services.
- Ingredients Operations revenue increased to $113.4 million from $37.8 million, primarily reflecting the October 2020 acquisition of Silva. Segment operating income was $7.1 million, compared with a $2.2 million loss. Management also cited strong human- and pet-food volumes and some demand recovery.
- Silva was acquired for approximately $164 million in cash, plus $5.9 million of working capital at acquisition. On October 4, 2021, after the reporting date, Universal acquired Shank’s Extracts for approximately $100 million in cash, funded with cash and revolving-credit borrowings; a related real-property purchase of approximately $13 million was expected to close in the third quarter of fiscal 2022.
Outlook, risks, contingencies, and unusual items
- No quantified earnings or revenue guidance is provided. Management expects tobacco crop shipments to be weighted toward the second half of fiscal 2022. It warned that shipping delays could push shipments into fiscal 2023, although the extent was not yet known.
- Management said current cash, operating cash flows, and available liquidity were expected to meet requirements for at least the next 12 months. It also cited global vessel and container constraints, rising freight and other inflationary costs, and labor constraints; ingredient operations could face higher costs later in the fiscal year.
- COVID-19 effects remain uncertain. The company said operations were fundamentally unchanged apart from shipping delays, but warned that the pandemic and related economic, market, and supply-chain developments could affect demand, operations, liquidity, and results. Other stated risks include customer concentration, crop supply and quality, weather, currency and interest-rate movements, regulation, litigation, and acquisition integration.
- Six-month results included $2.0 million of restructuring and impairment costs, associated with African tobacco operations and the wind-down of CIFI. A $2.5 million reversal of FruitSmart contingent consideration increased reported operating income. Acquisition transaction costs and tax items also affected reported-versus-adjusted results.
- The six-month effective tax rate was 16.5%, including a $1.7 million benefit from a final foreign tax ruling; management estimated approximately 22.0% without that benefit. The prior-year six-month tax rate included a $4.4 million tax benefit from final U.S. tax regulations.
- Brazil VAT assessments remained contested: approximately $9 million in Santa Catarina and $3 million in Parana, including relevant accumulated interest as described in the filing. Management considered loss not probable and recorded no liability; resolution may take a lengthy period. Other legal and tax matters were not expected to materially affect financial position, although an adverse outcome could materially affect a particular period.
- Variable-rate debt exposure was approximately $335 million; management estimated that a hypothetical 1% rate increase would raise annual interest expense by about $3.3 million, partly mitigated by customer charges. The company uses interest-rate and foreign-currency derivatives for risk management, not speculation.
Most important facts for investors to verify
- Confirm the intended reporting period: this filing is for fiscal 2022 Q2, not 2020 Q2.
- Track second-half tobacco shipment timing, especially the risk of delays into fiscal 2023, and the related seasonal inventory and borrowing needs.
- Assess whether Ingredients Operations’ improvement is sustainable after the Silva acquisition and how Shank’s acquisition and financing affect debt and returns.
- Monitor freight, inflation, labor, foreign-exchange, and interest-rate costs, as well as the company’s ability to pass costs through to customers.
- Review the contested Brazil VAT assessments and the recoverability of VAT credits; the filing reports approximately $55 million of gross recoverable credits and $20 million of valuation allowances.
- Reconcile cash-flow disclosures: the cash-flow statement reports six-month operating cash use of $120.8 million, while MD&A describes it as $121.3 million.